日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma

晚期黑色素瘤患者接受纳武利尤单抗联合伊匹木单抗治疗的最终10年疗效

Wolchok, Jedd D; Chiarion-Sileni, Vanna; Rutkowski, Piotr; Cowey, C Lance; Schadendorf, Dirk; Wagstaff, John; Queirolo, Paola; Dummer, Reinhard; Butler, Marcus O; Hill, Andrew G; Postow, Michael A; Gaudy-Marqueste, Caroline; Medina, Theresa; Lao, Christopher D; Walker, John; Márquez-Rodas, Iván; Haanen, John B A G; Guidoboni, Massimo; Maio, Michele; Schöffski, Patrick; Carlino, Matteo S; Sandhu, Shahneen; Lebbé, Céleste; Ascierto, Paolo A; Long, Georgina V; Ritchings, Corey; Nassar, Ayman; Askelson, Margarita; Benito, Melanie Pe; Wang, Wenjia; Hodi, F Stephen; Larkin, James

Phase 1b/2 study evaluating safety, efficacy and immune effects of TLR9 agonist cavrotolimod with anti-PD-1 antibodies among patients with advanced solid tumors

一项评估 TLR9 激动剂 cavrotolimod 与抗 PD-1 抗体联合治疗晚期实体瘤患者的安全性、有效性和免疫效应的 1b/2 期研究

Milhem, Mohammed M; Wise-Draper, Trisha M; Chandra, Sunandana; Hanna, Glenn J; Laux, Douglas E; Medina, Theresa M; Ansstas, George; Daud, Adil; Kelly, Ciara M; O'Day, Steven J; Perez, Cesar A; Wong, Michael K; Friedlander, Philip A; Kristedja, Timothy S; Burgess, Melissa A; Cowey, C Lance; Hanks, Brent A; Weight, Ryan M; Daniel, Weston L; Feltner, Douglas E; Mix, Scott; Sindelar, Laurel; Bexon, Alice S; Bexon, Martin F; Michel, Robert E; Bhatia, Shailender

Outcomes With Postrecurrence Systemic Therapy Following Adjuvant Checkpoint Inhibitor Treatment for Resected Melanoma in CheckMate 238

CheckMate 238 研究中接受辅助检查点抑制剂治疗的黑色素瘤切除术后复发患者接受全身治疗的疗效

Weber, Jeffrey; Del Vecchio, Michele; Mandalá, Mario; Gogas, Helen; Arance, Ana M; Dalle, Stephane; Cowey, C Lance; Schenker, Michael; Grob, Jean-Jacques; Chiarion-Sileni, Vanna; Márquez-Rodas, Iván; Butler, Marcus O; Di Giacomo, Anna Maria; de la Cruz-Merino, Luis; Arenberger, Petr; Atkinson, Victoria; Hill, Andrew; Fecher, Leslie A; Millward, Michael; Khushalani, Nikhil I; Queirolo, Paola; Long, Georgina V; Lobo, Maurice; Askelson, Margarita; Ascierto, Paolo A; Larkin, James

Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma

晚期黑色素瘤患者接受纳武利尤单抗联合伊匹木单抗或单用纳武利尤单抗治疗与单用伊匹木单抗治疗的长期疗效比较

Wolchok, Jedd D; Chiarion-Sileni, Vanna; Gonzalez, Rene; Grob, Jean-Jacques; Rutkowski, Piotr; Lao, Christopher D; Cowey, C Lance; Schadendorf, Dirk; Wagstaff, John; Dummer, Reinhard; Ferrucci, Pier Francesco; Smylie, Michael; Butler, Marcus O; Hill, Andrew; Márquez-Rodas, Ivan; Haanen, John B A G; Guidoboni, Massimo; Maio, Michele; Schöffski, Patrick; Carlino, Matteo S; Lebbé, Céleste; McArthur, Grant; Ascierto, Paolo A; Daniels, Gregory A; Long, Georgina V; Bas, Tuba; Ritchings, Corey; Larkin, James; Hodi, F Stephen

Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival

辅助性纳武利尤单抗治疗III/IV期黑色素瘤:安全性结果评估及其与无复发生存期的关系

Mandala, Mario; Larkin, James; Ascierto, Paolo Antonio; Del Vecchio, Michele; Gogas, Helen; Cowey, C Lance; Arance, Ana; Dalle, Stéphane; Schenker, Michael; Grob, Jean-Jacques; Chiarion-Sileni, Vanna; Marquez-Rodas, Ivan; Butler, Marcus O; Di Giacomo, Anna Maria; Lutzky, Jose; De La Cruz-Merino, Luis; Atkinson, Victoria; Arenberger, Petr; Hill, Andrew; Fecher, Leslie; Millward, Michael; Khushalani, Nikhil I; de Pril, Veerle; Lobo, Maurice; Weber, Jeffrey

Real-World Clinical Outcomes in Patients with Locally Advanced or Metastatic Merkel Cell Carcinoma Treated in U.S. Oncology Clinical Practices: Results from SPEAR-Merkel

美国肿瘤临床实践中局部晚期或转移性默克尔细胞癌患者的真实世界临床结果:SPEAR-Merkel 研究结果

Bhanegaonkar, Abhijeet; Liu, Frank X; Boyd, Marley; Fulcher, Nicole; Kim, Ruth; Krulewicz, Stan; Smith, Jodi; Cowey, C Lance

Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial

确定BRAFV600野生型转移性黑色素瘤的治疗方案:一项基于SU2C/MRA基因组学的临床试验

LoRusso, Patricia M; Sekulic, Aleksandar; Sosman, Jeffrey A; Liang, Winnie S; Carpten, John; Craig, David W; Solit, David B; Bryce, Alan H; Kiefer, Jeffrey A; Aldrich, Jessica; Nasser, Sara; Halperin, Rebecca; Byron, Sara A; Pilat, Mary Jo; Boerner, Scott A; Durecki, Diane; Hendricks, William P D; Enriquez, Daniel; Izatt, Tyler; Keats, Jonathan; Legendre, Christophe; Markovic, Svetomir N; Weise, Amy; Naveed, Fatima; Schmidt, Jessica; Basu, Gargi D; Sekar, Shobana; Adkins, Jonathan; Tassone, Erica; Sivaprakasam, Karthigayini; Zismann, Victoria; Calvert, Valerie S; Petricoin, Emanuel F; Fecher, Leslie Anne; Lao, Christopher; Eder, J Paul; Vogelzang, Nicholas J; Perlmutter, Jane; Gorman, Mark; Manica, Barbara; Fox, Lisa; Schork, Nicholas; Zelterman, Daniel; DeVeaux, Michelle; Joseph, Richard W; Cowey, C Lance; Trent, Jeffrey M

Clinical outcomes among unresectable, locally advanced, and metastatic cutaneous squamous cell carcinoma patients treated with systemic therapy

接受全身治疗的不可切除、局部晚期和转移性皮肤鳞状细胞癌患者的临床结果

Cowey, C Lance; Robert, Nicholas J; Espirito, Janet L; Davies, Kalatu; Frytak, Jennifer; Lowy, Israel; Fury, Matthew G

Efficacy, Safety, and Tolerability of Approved Combination BRAF and MEK Inhibitor Regimens for BRAF-Mutant Melanoma

已获批准的BRAF和MEK抑制剂联合疗法治疗BRAF突变型黑色素瘤的疗效、安全性和耐受性

Hamid, Omid; Cowey, C Lance; Offner, Michelle; Faries, Mark; Carvajal, Richard D

Real-world treatment patterns and clinical outcomes among patients with advanced melanoma: A retrospective, community oncology-based cohort study (A STROBE-compliant article)

晚期黑色素瘤患者的真实世界治疗模式和临床结果:一项基于社区肿瘤学的回顾性队列研究(符合STROBE标准的文章)

Cowey, C Lance; Liu, Frank Xiaoqing; Boyd, Marley; Aguilar, Kathleen M; Krepler, Clemens